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WE have provided evidence that: (a) lethality of mice
to crude  Bothrops venom varies  according  the iso-
genic strain (A/J > C57Bl/6 > A/Sn > BALB/c > C3H/
HePas  >  DBA/2  >  C3H/He);  (b)BALB/c  mice
(LD50=100.0 m g)  were  injected  i.p.  with  50 m g  of
venom produced IL-6, IL-10, INF-g , TNF-a and NO in
the serum. In vitro the cells from the mice injected
and  challenged  with the venom only released IL-10
while  peritoneal macrophages released IL-10,  INF-g
and  less amounts of  IL-6; (c)  establishment of local
inflammation  and  necrosis  induced  by  the  venom,
coincides with the peaks of TNF-a , IFN-g and NO and
the  damage  was  neutralized  when  the  venom  was
incubated  with  a  monoclonal  antibody  against  a
60 kDa  haemorrhagic  factor.  These  results  suggest
that susceptibility to Bothrops atrox venom is geneti-
cally dependent but MHC independent; that IL-6, IL-
10,  TNF-a ,  IFN-g and  NO  can  be  involved  in  the
mediation  of  tissue  damage;  and  that  the  major
venom  component  inducers  of  the  lesions  are
haemorrhagins.
Key  words:  Bothrops  atrox,  Cytokines, Animal  venoms,
Mediators of inflammation
Introduction
Bites by snakes belonging to the genus Bothrops sp.
can  result  in  an  immediate  local  lesion.  This  pro-
gresses  from  an  acute  inflammatory  reaction  to  an
impressive tissue destruction.
1 Systemic effects of the
venom  at  various  grades  of  severity  include  blood
incoagulability  and acute kidney failure.
2,3 Although
some  venom  components  are  endowed  with  the
ability  to  reproduce  in  experimental  animals  some
local or systemic lesions such as haemorrhage (hae-
morrhagins) and blood incoagulability (thrombin-like
factors) respectively, observations in human  victims
have  been  isolated  and  characterized,  the  intimate
events  elapsing from  the venom penetration  to the
establishment  of  the  lesions  are  not  yet  known.
Among  these  are  included  the  venom  components
and the host mediators involved in the recruitment of
leukocytes  from  the  circulation  to  the  site  of  the
tissue  injury,  the  elicitation  of  specific  leukocyte
populations, activation  or damage of the endothelial
cells lining  the post capillary  venules  at  the  site at
which  extravasation  of  leukocytes  and/or  erythro-
cytes occur.
4
In order to address these issues, basic information
obtained  in  a  representative  experimental  animal
model using  adequate  venom samples as  inflamma-
tory  inducer  are  needed.  Previous  reports  have
shown that susceptibility to Crotalus durissus terrifi-
cus venom varies according to the strain of mice used,
A/J  and  DBA/2  have  been  shown  to  be  the  most
susceptible and BALB/c and C57Bl/6 the most resist-
ant strains.
5
It is well known that lethality and toxicity of snake
venoms can vary according to the age, sex, nutritional
state and geographic regions where the animal were
captured.
6
Thus,  aiming  to  minimize  the  experimental  bias
BALB/c mice, a strain of mice moderately susceptible
to the B. atrox venom action and a mixture of venom
obtained  from  several  adult  snakes  from  the  same
geographic  region  were  used  throughout  all
experiments.
The present study shows: that the susceptibility to B.
atrox venom varies according to the strain of mice and
that cytokines are released in vivo during envenoming
and in vitro upon stimulation with the venom. The
inflammatory effects induced by this venom are also
described at microspical level. As haemorrhage is one
of  most  conspicuous  tissue  lesions  produced  by
Bothrops sp. venom, the blocking action of a mono-
clonal antibody against a haemorrhagic factor present
in B. atrox venom was tested.
Materials and methods
Chemicals, reagents and buffers
RPMI  1640  medium,  actynomycin  D,  ortho-phenyl-
diamine  (OPD),  nicotinamide-adenine  dinucleotide
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(FAD),  sodium  nitrate  reductase,  polyoxyethilene
sorbitan (Tween 20), Concanavalin A (Con A) and LPS
serotype  O111:B4  were  purchased  from  Sigma  (St
Louis,  MO),  fetal  calf  serum  (FCS)  was  purchased
from  Fazenda  Pig  (Rio  de  Janeiro),  murine  anti-IL-6
(clones: MP5–20F3 and MP5–32.C.11), rIL-6, anti-IL-
10  (clones  JESS-2A5  and  SXC-1),  rIL-10,  anti-IFN-g
(clones XMG 1.2, AN18), rIFN-g were purchased from
PharMingen  (Toreyana,  San  Diego)  and  rTNF-a was
from Boehringer Mannheim (Indianapolis).
Venoms
Bothrops atrox, venom, was provided by the Labo-
rat´ orio de Herpetologia, Instituto Butantan, S˜ ao Paulo,
Brazil. The venom was collected, pooled, lyophilized
and stored at –20°C. Samples were prepared in 0.15 M
phosphate buffered saline (PBS) pH 7.2 at use.
Animals









a) weighing  18–22 g and aged 5–6
weeks, were obtained from the Biot´ erio de Camundon-
gos Isogˆ enicos, Universidade de S˜ ao Paulo, S˜ ao Paulo,
Brazil  and  used  throughout  the  experiments.  The
animals were maintained and used under strict ethical
conditions  according  to  the  animal  welfare  inter-
national  recommendations  (Commitee  Members,
International Society on Toxinology, 1991).
Antibodies
A monoclonal antibody against a haemorrhagic factor
recognizing a  60 kDa component  was prepared and
immunochemically  analysed  by  the  authors  (manu-
script in preparation).
Lethality and LD50 calculation
The lethal toxicity of B. atrox venom was assessed in
isogenic  mouse  strains  by  intradermal  injection  of
different venom concentrations in 0.1ml of 0.85% NaCl
solution. Five animals were used for each venom dose.
The  LD50 was  determined  by  the  Spearman-Karber
method
7 and calculated according to probit analysis.
8
Venom treatment
Groups of four mice per group were injected i.p. with
500 m l of saline containing 50 m g of venom.
Sera and cell suspensions
Blood was collected from the retro-orbital plexus at
different  times  after  venom  injection.  Cells  were
obtained either from spleens or from the peritoneal
cavity  of  mice  previously  injected  with  50 m g  of
venom.
Cell culture supernatants
Spleen  cells  were  obtained  from  venom  or  saline
injected  mice  3 h  before  harvesting.  Cells  were
cultured in supplemented RPMI-1640 medium at 10
5
cells/well in 5% CO2 at 37°C. Cells received in vitro
either 250 ng of venom or 1 m g of LPS or 1 m g of Con A.
Adherent peritoneal cells were collected from the
same donors of spleen cells. Cells were cultured in
RPMI-1640  medium  supplemented  with  2-ME,
L-glutamine, and 5% FCS, and left to adhere onto 24
microwell plates for 24 h at a initial concentration of
10
6 cells/well  in  5%  CO2 at  37°C  before  in  vitro
addition of 250 ng of venom or 1 m g of LPS. Super-
natants were collected at 48 h of culture.
IL-6, IFN-g and IL-10 concentrations in serum or
spleen or adherent peritoneal cell cultures
The  presence  of  cytokines  IL-6,  IL-10  and  IFN-g in
mouse sera was determined by indirect ELISA follow-
ing  the  procedures  described  elsewhere.
9 Briefly,
ELISA  plates  were  coated  with  100 m l  (1 m g/ml)  of
monoclonal antibodies anti-IL-6, anti IFN-g or anti-IL-
10 in 0.1 M sodium carbonate coating buffer, pH 8.2,
and incubated for 6 h at room temperature. The wells
were  then  washed  with  0.1%  PBS/Tween  20  and
blocked with 100 m l of FCS 10% PBS for 2 h at room
temperature. After washing, duplicate mouse serum
samples of 50 m l were added to each well. Recombi-
nant murine cytokines were used to generate stand-
ard curves. After 18 h of incubation at 4°C the wells
were washed and incubated with 100 m l (2 m g/ml) of
the biotinylated monoclonal antibodies anti-IL-6, anti-
IFN-g or anti-IL-10 respectively as second antibodies
for 45 min at room temperature. After a final wash, the
reaction  was  developed  by  the  addition  of OPD  to
each well. Optical densities were measured at 405 nm
in a microplate reader. IL-6, IFN-g and IL-10 levels are
expressed  as  ng/ml. The  detection  limits  of  these
assays were 0.78 ng/ml for IL-6 and IL-10 and 7.8 ng/
ml for IFN-g .
TNF-a concentration in serum or spleen or
adherent peritoneal cell cultures
The presence of TNF-a in mice sera was evaluated by
the method of Ruff and Gifford.
10 Briefly, L929 cells
maintained in RPMI 1640 medium supplemented with
5%  FCS  were  plated  at  3  3 10
5 cells/well  on  a
96-multiwell tissue culture plate and incubated at 37°C
for 18 h in a 5% CO2 atmosphere. Duplicate samples of
100 m l  of  mouse  sera  collected  from  the  saline  or
venom injected animals were serially diluted in RPMI
1640 medium containing 1.0 m g/ml of actinomycin D
S. F. Barros et al.
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incubation, the supernatants were removed and the
remaining  live  cells  assessed  by  fixing  and  staining
with 1% crystal violet. Absorbance [A] was measured in
each well at 620 nm in a microplate reader. Cytotox-
icity was calculated by the formula:
Cytotoxicity = A control – A sample 3 100/A
control
Titres were calculated as the reciprocal of the dilution
of  the  sample  in  which  50%  of  the  cells  in  the
monolayers were lysed. TNF-a activity is expressed as
ng/ml, estimated from the ratio  of a  50% cytotoxic
dose  of  the  test  to  that  of  the  standard  mouse
recombinant TNF-a The detection limit of this assay
was 3.429pg/ml.
Nitrite concentration in serum, spleen or
adherent peritoneal cell cultures
The nitrite levels in mice serum as an indication of
NO  production  were  determined  as  described  pre-
viously.
11 Briefly, 40 m l of each mouse serum sample
were incubated in a 96- well, flat-bottom plate with
40 m l of the reduction solution (NADPH 1.25 mg/ml;
FAD 10.4 mg/ml; KH2 PO4 0.125 M) containing 0.5 U
NO2
– reductase for 2h at 37°C; after incubation, 80 m l
of  Griess  reagent  (0.1%  naphtylenediamine  hydro-
cloride, 1% sulphonylamide, 3% H3PO4) were added
to each well. The optical densities were measured at
540 nm in a micro plate reader. NO2
– concentrations
were  determined using  a  standard  curve  of  NaNO3
ranging from 1.25 to 270 mM and expressed as nmol/
10
5 cells. Nitrite levels in the cell culture supernatants
were determined by mixing equal volume of Griess
reagent and and processed as above.
Results
Determination of LD50
Groups of five BALB/c, C3H/He, C3H/Pas, C57Bl/6,
DBA/2, A/J  and A/Sn  mice  were  injected  i.p.  with
different doses of B. atrox crude venom and the death
survival ratio  determined after 48 h. The LD50 value
was calculated by probit analysis at 95% confidence.
As shown in Table 1 the LD50 were:137.0 m g, 136.0 m g
and  129.0 m g  for  DBA/2,  C3H/HePas  and  C3H/He
respectively  and  100.0 m g,  95.2 m g,  90.8 m g  and
89.4 m g  for  BALB/c,  A/Sn,  C57Bl/6  and  A/J  strains
respectively.
Local inflammatory reaction induced by crude
Bothrops atrox venom
Subcutaneous  injection  of  50 m g  of  crude  B.  atrox
venom  induces  an  inflammatory  reaction  charac-
terized  macroscopically  by  an  early  appearance  of
edema and erythema followed later by intense haem-
orrhage  culminating  in  local  tissue  necrosis.  Frag-
ments of tissues collected from the injected sites after
24  and  48 h,  showed  the  presence  of  a  leukocyte
infiltrate rich in polymorphonuclear cells with some
macrophages,  lymphocytes  and  erythrocytes
immersed in a hyaline exudate (Fig. 1A). As indicated
by the arrows the skeletal muscle cells surrounded by
the infiltrating leukocytes are disrupted. In contrast,
fragments of tissues collected from the corresponding
skin  sites  injected  with  the  same  doses  of  crude
venom  pre-incubated  with  a  monoclonal  antibody
against  a  60kDa  purified  haemorrhagic  component
did not show patent inflammatory signals except for
the  presence  of  a  discrete  exudate  between  the
skeletal muscle cells (Fig. 1B).
In vivo inflammatory cytokines and nitrite
release upon venom injection
Groups of BALB/c mice were injected i.p. with 50 m g
of  B.  atrox venom  and  samples  of  blood  were
collected after 2, 4, 12, 18 and 24 h. Cytokines and
NO2
– were individually titrated in the sera. IL-6, IL-10
and  IFN-g attained  maximal  release  after  4 h  (Fig.
2A,B,C). following venom injection, while a second
peak for IFN-g was at 12 h TNF-a started to appear
after 4 h attaining a peak at 6 h declining  thereafter
(Fig. 2D). NO2
– starts to appear at 2 h attaining a peak
at 4 h and declining at 6 h (Fig. 2E).
Ex vivo inflammatory cytokines and nitrite
release upon venom injection
The  cytokines  which  were  detected  in  serum  are
mostly  synthesized  by  macrophages.  In  order  to
better understand  the mechanism of the cell activa-
tion  by  venom  spleen  cells  or  adherent  peritoneal
cells obtained from the same mice pre-stimulated in
vivo with  B.  atrox venom  were  analysed  in
cultures.
Inflammation by B. atrox venom
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Table 1. Susceptibility to Bothrops atrox venom of different
strains of isogenic mice
Strain* Haplotype DL 50**
BALB/c a 100.0 (80–120)
C3H/He k 129.0 (91–169)
C3H/HePas k 136.0 (136–179)
C57BI/6 b 90.8 (81–105)
DBA/2 d 137.0 (116–189)
A/J a 89.4 (82–97)
A/Sn a 95.2 (86–112)
*Mouse 20 ± 2g.
**95% confidence limit.
Mice were  i.p.  injected  with  different  venom concentrations  of B.
atrox venom. DL 50% was estimated by probit analysis.Splenocytes
Groups  of  BALB/c  mice  were  injected  ip  with
venom 3h before cell harvesting. Venom, LPS or Con
A were added to splenocyte cultures and IL-6, IL-10,
IFN-g ,  TNF-a and  NO2
– were  measured  in  these
supernatants  after  48 h.  Figure  3A  shows  that  in
contrast with LPS and Con A the addition of venom
to cells obtained either from mice previously injec-
ted  with  saline  or  venom  does  not  induce  IL-6
release. Release  of  IL-10,  however,  was  induced  by
venom,  LPS  and  Con  A  either  in  animals  injected
with venom or with saline ( Fig. 3B). Release of IFN-
g was only obtained by Con A. (Fig. 3C). TNF-a and
NO2
– were not detected in these supernatants (data
not  shown).
Resident adherent cells
Figure 4  shows  that  resident  peritoneal cells either
obtained from animals injected with venom or saline
produce significant amounts of IL-6, IL-10 and IFN-g
after venom or LPS challenge. TNF-a and NO2
– were
not  detected  in  these  supernatants  (data  not
shown).
Discussion
These data have shown that subcutaneous injection of
B. atrox crude venom in mice induced a set of gross
inflammatory  signals:  plasma  exudation,  leukocyte
migration, vascular wall damage resulting in haemor-
rhage and skeletal muscle cell disruption. Some or all
of these effects caused by B. atrox venom have been
already  described either in  human  victims of snake
bite  or  in  experimentally  injected  animals.
12,13 The
aim of this work has been to provide an experimental
model to study in vivo and in vitro the production
and  release  of  mediators  (pro-inflammatory  sub-
stances  and  cytokines)  known  to  be  involved  in
leukocyte migration, vascular wall damage and in cell
activity or death
14 and to analyse the lesions induced
by  B.  atrox crude  venom.  Such  an  experimental
model  should  involve  animals  genetically  homoge-
S. F. Barros et al.
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FIG. 1. Photomicrography of subcutaneous tissues obtained from: (A) BALB/c mices.c. injected with 50m g of B. atrox venom,
tissue samples were collected 24h after fixed in 10%  paraformaldehyde and HE stained. (B) BALB/c mices.c. injected with 50m g
of B. atrox venom previously incubated with 50m l of monoclonal antibody (59.1) against 60kDa haemorrhagic factor.Arrows
indicate PMN, macrophages, lymphocytes and a disrupted capillary. Magnification 300 3 .
(A) (B)neous and moderately susceptible to the venom toxic
effects, as well as venom samples containing all the
presumptive toxic components. This was achieved by
pre-determining  the  LD50 of  the  venom  in  several
isogenic strains of mice. Among the analysed strains
A/Sn, A/J and C57Bl/6 were significantly more suscep-
tible to the venom lethal effects than C3H/He, C3H/
HePas and DBA/2 resistant strains. BALB/c mice were
found  to  be  a  moderately  susceptible  strain.  The
genetic influence on an experimental animal suscepti-
bility  to the lethal venom action is not novel, since
genetic background also influences susceptibility  of
mice to the lethal activity present in C. d. terrificus
venom.
5 Distribution of susceptibility or resistance to
the  lethal  activities  of  the  venoms  among  different
mouse  strains  varies  according  to  the  species  of
Inflammation by B. atrox venom
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FIG. 2. Cytokine release in serum of BALB/c mice ip injected with 50m g of Bothrops atroxvenom. Blood was collected at 2, 4,
6, 8 12, 18 and 24h and control blood was collected from saline injected mice.The presence of (A) IL-6, (B) IL-10, (C) INF-g was
determined by ELISA; (D) TNF-a was assayed by its cytotoxic effect on L929 cells; (E) NO was determined by a modification of
the Griess method. Each point represents the mean ± SD of duplicate samples.venom. A/J and DBA/2 mice are the most susceptible
to the C. d. terrificus and are the most resistant to the
B. atrox venom. These observations are compatible
with the fact that while in C. d. terrificus venom the
lethality is confined to neurotoxins such as crotamine
and crotoxin, in Bothrops sp. the lethality appears to
be  dependent  on  the  inflammatory  factors  such  as
thrombin-like,  haemorrhagins,  phospholipases  and
proteases enzymes.
Plasma exudation and oedema at the skin sites of
venom injection can be at least partially explained by
local release of the well-known mediators of the early
events  of  the  acute  inflammatory  events  such  as
bradykinin
15 and anaphylatoxins.
16 In fact Bothrops
venom  contains  proteolytic  enzymes  capable  of
promoting in vitro cleavage of plasma kallikreinogen
and/or  the  complement  components  C3  and  C5,
releasing  bradykinin
15 and  C3a  and  C5a,
17 respec-
tively. The local release of these vasoactive peptides
although presumptive  has not  yet been  experimen-
tally  proven.  Although  C3a  and  C5a  are  potent
chemoattractants  for  PMN  leukocytes  and  mono-
cytes,
18 accumulation of macrophage-like cells, lym-
phocyte  scattering among the inflamed tissues, the
cell wall damage and skeletal muscle cells disruption
cannot be explained by the local formation of those
mediators. Published results obtained in other inflam-
S. F. Barros et al.
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FIG. 3. Ex vivo cytokine release in supernatants of spleen
cells collected from BALB/c mice i.p. injected with 50m g of B.
atrox venom. Spleen cells were harvested 3h after saline or
venom injection, maintained in vitro and challenged either
with 250ng of venom, 1m g of LPS or with 1m g of Con A and
incubated for 48h (A) IL-6, (B) IL-10, (C) INF-g , were assayed
by ELISA. Each point represents the mean ± SD of duplicate
samples of four animals.
FIG. 4. Ex vivo cytokine release in supernatants of spleen
cells collected from of BALB/c mice ip injected with 50m g of
B. atroxvenom. Adherent peritoneal cells were harvested 3h
after  saline  or  venom  injection,  maintained  in  vitro and
challenged either with 250ng of venom or 1m g of LPS and
incubated for 48h. (A) IL-6, (B) IL-10, (C) INF-g , were assayed
by ELISA. Each point represents the mean ± SD of duplicate
samples of four animals.matory models have indicated that pro-inflammatory
substances and some cytokines are deeply involved in
the activation of the endothelial cells and leukocytes
leading them to express on their cell surface adhesion
molecules as E-selectin and P-selectin and the corre-
sponding specific ligands PSGL-1 and Sialyl Lewis and
others.
19 Besides,  some  cytokines  such  as  IL-8  are
chemoattractants  for  basophils  and  T  lympho-
cytes
20–22 and potent activators of these cells.
23
The  cytokine  profiles  observed  in  vivo upon  B.
atrox venom injection shows that production of IL-6,
IL-10  and  IFN-g attained  maximal  values  at  4 h
following venom injection. While the first two cyto-
kines  decay  along  the  following  hours  becoming
almost undectable, IFN-g serum levels attain a second
higher peak 12 h later. TNF-a in contrast, appears at a
later time in serum reaching high amounts 18 h after
the venom injection (Fig. 2). NO2
– serum levels, on
the  other  hand,  starts  to  appear  even  before  4 h.
following  venom  injection  increasing  slowly  but
consistently reaching maximal values after 24 h. These
results agree with previous reports showing that IL-6
is  released  in  Swiss  mice  injected  with  B.  asper
venom
13 and human victims of snake bite.
12 Although
the first authors were not able to detect TNF-a in mice
injected  with  B.  asper venom,  others  presented
indirect evidence indicating that this cytokine can be
produced  along  envenomation  by  snake  venom.
24
These  authors  provided  evidence  that  metallo-pro-
teases  from  B.  jararaca and  Echis  pyramidium
leakey venoms can cleave pro-TNF-a into its mature
form in vitro. Besides, they have shown that TNF-a
antibody significantly reduced the resultant necrotic
lesions in mice injected with E. p. leakey venom. IL-10
is  capable  of  mediating  suppression  on  activated
macrophages  and  monocytes  leading  to  striking
down-regulation  of  numerous  inflammatory  mono-
kines as TNF-a , IL-1,IL-6, IL-8, GM-CSF and G-CSF .
25,26
IL-10  is  also  capable  of  effectively  protecting  mice
from endotoxin-induced shock, a lethal inflammatory
reaction mediated by monokines as TNF-a and IL-10.
27
A similar suppressor effect of IL-10 was also found on
NO production by activated macrophages.
28 Our data
shows that the IL-10 peak at 4 h after venom injection
coincides with TNF-a and NO2
– low serum levels are
compatible with these observations.
Some  coincidences  or  discrepancies  were  also
observed when cytokine production was analysed in
vitro using either spleen cells or adherent peritoneal
cells obtained from BALB/c mice injected and  chal-
lenged ex vivo with venom: (a) IL-6 was not produced
by  spleen  cells;  (b)  IL-10  was  produced  both  by
spleen or peritoneal cells; (c) IFN-g was produced by
adherent peritoneal cells but not by spleen  cells.As
the in vivo venom stimulated cells responded in vitro
to the classical cytokine inducers, these discrepancies
cannot  be  imputed  to  general  deregulation  of  the
machinery used to produce cytokines. Production of
IL-10  by  spleen  cells  and  peritoneal  adherent  cells
agrees with the well-established observations show-
ing that this cytokine is produced by a large array of
cells in which T and B lymphocytes and macrophages
are included.
29 Depending on the relapsing time, the
production  of  the  various  cytokines  will  be  influ-
enced  by  the  ones  that  are  first  released  into  the
surrounding millieu, interfering therefore with matu-
ration or secretion of the others or with the expres-
sion of their correspondent receptors.
The discrepancies detected in the cytokine profiles
produced in vivo and ex vivo can be explained by the
interplay involving the factors governing the produc-
tion  of  the  concerned  proteins,  the  lack  of  some
essential factors for the synthesis or expression of a
particular  cytokine or  by  the low  sensitivity  of  the
assay  methods  of  detecting  smaller  amounts  of
cytokines. As  a  monoclonal  antibody  specific  for  a
60 kDa  B.  atrox haemorrhagic  factor  was  able  to
block leukocyte infiltration and  haemorrhagic activ-
ities  of  the  venom.  Such  findings  suggest  that  the
haemorrhagic components could be the conspicuous
inflammatory  inducers  present  in  the  venom. The
monoclonal  certainly  recognizes  and  blocks  the
action  of  the  haemorrhagic  factor  presumably  by
combining with a functionally important epitope.
On the basis of our data, we can hypothesize that B.
atrox venom  can  trigger various host inflammatory
mechanisms by using the same or some components
acting in concert: (a) the early plasma exudation can
be  mediated  by  local  release  of  bradykinin  and
histamin; (b) polymorphonuclear cells adherence and
migration may be triggered by C3a, C5a and or IL-8;
(c)  the  endothelial  cells  belonging  to  the  blood
vessels  crossing  the  tissue  sites  injected  with  the
venom  can  be  activated  and  express  P-selectin  and
E-selectin  under  the  paracrinal  action  of  histamine,
thrombin-like  factor  and  TNF-a ;  (d)  basophils  and
lymphocyte  accumulation  can  be mediated  by  IL-8;
and (e) skeletal muscle cell disruption can be induced
either  directly  by  enzymes as  proteases,  phospholi-
pase  A2,  haemorrhagins  or  even  other  cytolitic
components present  in the venom, or indirectly by
mediators released from invading leukocytes.
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